Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Collegium Pharma
(NQ:
COLL
)
36.26
+0.22 (+0.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Collegium Pharma
< Previous
1
2
3
Next >
Organon Stock Earns Relative Strength Rating Upgrade; Hits Key Threshold
August 20, 2024
On Tuesday, generic drug maker Organon stock had its Relative Strength (RS) Rating upgraded to 83, up from 78 a day earlier.
Via
Investor's Business Daily
The Analyst Verdict: Collegium Pharmaceutical In The Eyes Of 4 Experts
August 09, 2024
Via
Benzinga
COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
In a market where value is scarce, NASDAQ:COLL offers a refreshing opportunity with its solid fundamentals.
August 06, 2024
COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is probably undervalued for the fundamentals it is displaying.
Via
Chartmill
NASDAQ:COLL is an undervalued gem with solid fundamentals.
July 16, 2024
COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is probably undervalued for the fundamentals it is displaying.
Via
Chartmill
Dr. Reddy's Labs Stock Sees Improved Technical Strength
June 28, 2024
On Friday, Dr. Reddy's Labs ADR stock earned an upgrade to its Relative Strength (RS) Rating, from 66 to 76.
Via
Investor's Business Daily
Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews
May 10, 2024
Via
Benzinga
Critical Insights From Collegium Pharmaceutical Analyst Ratings: What You Need To Know
April 11, 2024
Via
Benzinga
Where Collegium Pharmaceutical Stands With Analysts
February 23, 2024
Via
Benzinga
7 Biotech Stocks to Buy on the Dip: June 2024
June 24, 2024
With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation.
Via
InvestorPlace
NASDAQ:COLL appears to be flying under the radar despite its strong fundamentals.
June 24, 2024
COLLEGIUM PHARMACEUTICAL INC (NASDAQ:COLL) is an undervalued gem with solid fundamentals.
Via
Chartmill
COLL Stock Earnings: Collegium Pharmaceutical Beats EPS, Misses Revenue for Q1 2024
May 09, 2024
COLL stock results show that Collegium Pharmaceutical beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Recap: Collegium Pharmaceutical Q4 Earnings
February 22, 2024
Via
Benzinga
Analyst Expectations For Collegium Pharmaceutical's Future
February 02, 2024
Via
Benzinga
Why Collegium Pharmaceutical Shares Are Gaining Today
January 03, 2024
Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial
Via
Benzinga
Recap: Collegium Pharmaceutical Q3 Earnings
November 07, 2023
Via
Benzinga
Needham Maintains Buy Rating for Collegium Pharmaceutical: Here's What You Need To Know
August 25, 2023
Via
Benzinga
Recap: Collegium Pharmaceutical Q1 Earnings
May 04, 2023
Via
Benzinga
Earnings Outlook For Collegium Pharmaceutical
February 22, 2023
Via
Benzinga
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday
January 03, 2024
U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during Wednesday’s session after it disclosed receiving a...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Atlassian, Universal Display, Booking, Dropbox And Other Big Stocks Moving Higher On Friday
August 04, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Friday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
February 07, 2023
Via
Benzinga
Analyst Sees This 'Specialty Pharma' Stock Stuck Until Prescription Trends Improve
August 08, 2022
Via
Benzinga
Recap: Collegium Pharmaceutical Q1 Earnings
May 10, 2022
Collegium Pharmaceutical (NASDAQ:COLL) reported its Q1 earnings results on Tuesday, May 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 07, 2023
It's time to start the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
February 06, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 8, 2022
August 08, 2022
Via
Benzinga
7 Micro-Cap Stocks to Take a Chance on Now
June 04, 2022
Despite (or because of) their size, some micro-cap stocks, have good value and are overlooked and should be considered by investors.
Via
InvestorPlace
A Preview Of Collegium Pharmaceutical's Earnings
May 09, 2022
Collegium Pharmaceutical (NASDAQ:COLL) is set to give its latest quarterly earnings report on Tuesday, 2022-05-10. Here's what investors need to know before the announcement. Analysts estimate that...
Via
Benzinga
5 Value Stocks To Watch In The Healthcare Sector
May 09, 2022
What Defines a Value Stock?
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.